Henrik F. Bauer

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Journal: Bone & joint open

Published: May 31, 2026

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Journal: Bone & joint open

Published: May 31, 2026

A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

Journal: The bone & joint journal

Published: November 30, 2025

What is debridement, antibiotics, and implant retention in orthopaedic oncology? : a global cross-sectional survey of surgeons' practices and opinions.

What is debridement, antibiotics, and implant retention in orthopaedic oncology? : a global cross-sectional survey of surgeons' practices and opinions.

Journal: Bone & joint open

Published: November 19, 2025

Disparities in disease presentation and survival after pathological fracture surgery at a middle- and a high-income centre.

Disparities in disease presentation and survival after pathological fracture surgery at a middle- and a high-income centre.

Journal: BMC surgery

Published: November 13, 2025

Identifying consensus and areas for future research in chondrosarcoma : a report from the Birmingham Orthopaedic Oncology Meeting.

Identifying consensus and areas for future research in chondrosarcoma : a report from the Birmingham Orthopaedic Oncology Meeting.

Journal: The bone & joint journal

Published: January 31, 2025

Outcome of surgical treatment for bone metastases caused by colorectal cancer.

Outcome of surgical treatment for bone metastases caused by colorectal cancer.

Journal: Journal of gastrointestinal oncology

Published: February 24, 2021

Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study.

Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study.

Journal: Clinical sarcoma research

Published: July 28, 2020

Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development.

Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development.

Journal: Cancer genetics

Published: June 20, 2019

Outcome of Surgical Treatment for Spinal Cord Compression in Patients With Hematological Malignancy.

Outcome of Surgical Treatment for Spinal Cord Compression in Patients With Hematological Malignancy.

Journal: International journal of spine surgery

Published: May 28, 2019

Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).

Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 12, 2018

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

Journal: British journal of cancer

Published: March 22, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026